Medtronic Cardio/Neuro Buys Stimulate Wall Street In 1998 - Stock Up 42%
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's tried and true ability to post solid operating results while simultaneously revamping its product profile to meet shifting market demands provided Wall Street with a dual reason to reward the firm's share price in 1998. The company's stock gained 41.5%, or 21-3/4 points, to close the year at 74-9/32.